DIVISION OF CARDIOLOGY - summary OF WEEKLY ROUNDS SCHEDULE

MONDAY, MARCH 7 to FRIDAY, MARCH 11, 2016

Monday, March 7:

8:00-9:00 / Aud B UH,
B2-116 VH &
B2-075
St. Joseph’s
OTN Event #
50410414 / Cardiovascular Grand Rounds Presenter: I. Hramiak
Title of Presentation: Cardiovascular Safety Trials in Individuals with Type 2 Diabetes
Learning Objectives:
1. To present data from cardiovascular outcome trials using DDP4 inhibitors, GLP analogs and SGLT2 inhibitors.
2. To discuss efficacy and safety data from these trials.
3. To indicate which trials are remaining to report in the next few years.
12:00-1:30 / Adult Congenital Cardiac Surgery Rounds – Videoconference from Toronto Rounds cancelled

Tuesday, March 8:

7:00-8:00 / B6-115 UH
OTN Event #
51365651 / Complex Revascularization Rounds Presenters: CV Surgeons & Interventional Cardiologists
Faculty Supervisors: D. Nagpal & P. Garg
Case-based presentation and discussion
Learning Objectives:
1. To develop a systematic approach to interpretation of coronary angiograms.
2. To discuss interesting case examples and their management.
3. To apply an evidence-based approach to complex revascularization cases in order to improve outcomes.
12:00-1:00 / Aud C UH / DOM ECG Session Presenter: K. Sidhu
2:00-5:00 / B6-128 UH / DIDACTIC EDUCATION SESSIONS:
2:00-3:00 / B6-128 UH / ACS: Endothelial function (BSS) Presenter: A. Sachedina Faculty Supervisor: S. Siu
Learning Objectives: by the end of this presentation we will:
1. Review the normal function of the endothelium.
2. Review methods of measuring endothelial function.
3. Review the pathophysiology of endothelial dysfunction.
3:00-4:00 / B6-128 UH / ECHO: Mitral regurgitation Presenter: V. Randhawa Faculty Suypervisor: B. Dias
Learning Objectives:
1. To review the common etiologies of acute and chronic mitral regurgitation by echocardiography.
2. To learn how to define the severity of mitral regurgitation by echocardiography.
3. To review the latest guidelines for management of mitral regurgitation.
4:00-5:30 / B6-128 UH / Clinical Diagnosis Rounds Presenter: D. Boughner

Wednesday, March 9:

8:00-9:00 / B6-115 UH
OTN Event #
50202812 / EP Rounds: Technology Rounds Presenters: Attendings & Fellows
Learning Objectives:
1. To review technological advances in EP.
2. To provide an overview of the principles behind the technology.
3. To review and clinical uses of the technology.
12:00-1:00 / B6-115 UH &
C2-504 VH
OTN Event #
46453692 / Adult Congenital Cardiac Teaching Rounds - Videoconference from Toronto
Presenter: L. Benson
Title of Presentation: A New Percutaneous Pulmonary Valve: The Venus-P Valve
1:00-4:00 / DSB1002
Western / PGME Academic Half Day: Accounting Principles
Presenters: B. Walton & R. Santos
Title of Presentation: Transition to Practice: Accounting Principles

Thursday, March 10:

8:00-9:00 / B6-128 UH / Graphics Rounds: Cath Presenter: P. Diamantouros
5:30 pm / The Black Trumpet, 523 Richmond Street, London
519.850.1500
Sponsor:
Michael Riley,
Novartis Pharmaceuticals Inc. / Journal Club Attendance open to Residents, Fellows and Division Members. RSVP to Charlene Grass (ext. 33830 or email )
Presenter: R. Matiasz Faculty Supervisor: P. Diamantouros
Paper for Presentation: Reduction in Total Cardiovascular Events With Ezetimibe/Simvastatin Post-Acute Coronary Syndrome The IMPROVE-IT Trial. S.A. Murphy, MPH, C.P. Cannon, MD, et al. JACC Vol. 67, No. 4, 2016
Learning Objectives:
1. To review existing literature on lipids and secondary prevention.
2. Critical analysis of the IMPROVE-IT trial.
3. Discussion.

Friday, March 11:

8:00-9:00 / B6-128 UH / EP Tracing Rounds: Case Presentations with ECG and Intra-cardiac tracings
Presenters: Attendings Fellows
Learning Objectives:
1. To develop a systematic approach to EP tracings.
2. To discuss interesting case examples.
3. To review electrophysiology principles and concepts.

Some of these educational activities/rounds are an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification program of The Royal College of Physicians and Surgeons of Canada, approved by the Division of Cardiology Education Committee - Western University.

Supported by unrestricted grants-in-aid provided by:

Aegerion Pharmaceuticals (Juxtapid (lomitapide)), Amgen Canada Inc. (Repatha), AstraZeneca Canada Inc. (Brilinta (Ticagrelor)),

Bayer HealthCare Pharmaceuticals (XARELTO® rivaroxaban tablet), Boehringer Ingelheim (Canada) Ltd. (Pradax (dabigatran), Twynsta (telmisartan/amlodipine)), Bristol-Myers Squibb Canada & Pfizer Canada Inc., (Eliquis (apixaban)), Medtronic of Canada Inc., Merck (Ezetrol, Olmetec®), Novartis Pharmaceuticals of Canada Inc. (Entresto), Servier Canada Inc. (Coversyl)